Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm Prospective Study to Investigate the Impact of Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) on Sexual Dysfunction in Unfavorable Intermediate Risk Prostate Cancer

NCT07460726 is registered in ClinicalTrials.gov with CancerCare Manitoba as lead sponsor.

NCT NCT07460726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07460726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm Prospective Study to Investigate the Impact of Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) on Sexual Dysfunction in Unfavorable Intermediate Risk Prostate Cancer
Lead sponsor
CancerCare Manitoba
Phase
Observational
Overall status
Not yet recruiting
Start date
March 16, 2026
Completion date
December 31, 2029
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile abnormalities, prostate cancer (adenocarcinoma), sexual dysfunction male